Rixing Bio-Tech

Rixing Bio-Tech engaged in the research and development of anthraquinone, ammonia sugar and other fine chemical products.

Number of Funding Rounds

Total Funding Amount

4

¥259M

Rixing Bio-Tech has raised a total of ¥259M in funding over 2 rounds. Their latest funding was raised on Mar 31, 2018 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 31, 2018	Post-IPO Equity	¥50M	1	—	—	Detail
Feb 17, 2017	Post-IPO Equity	¥102M	6	—	—	Detail
Sep 9, 2015	Series Unknown	¥57M	2	—	—	Detail
Sep 9, 2013	Series Unknown	¥50M	1	Gaoyoushi Guoyou Zichan Guanli Zhongxin	—	Detail

Number of Lead Investors

Number of Investors

1

10

Rixing Bio-Tech is funded by 10 investors. Gaoyoushi Guoyou Zichan Guanli Zhongxin and Jingxin Investment are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gaoyoushi Guoyou Zichan Guanli Zhongxin	Yes	Series Unknown
Jingxin Investment	—	Post-IPO Equity
Yangzhou Forever Software	—	Post-IPO Equity
Fudexinmao Touzi	—	Post-IPO Equity
Jiangsu One Belt One Road Investment Fund	—	Post-IPO Equity
Qunxiangdao Capital	—	Post-IPO Equity
Suzhou Gancheng	—	Post-IPO Equity
Longteng Rural Microfinance	—	Post-IPO Equity
Jiaxing Huicheng	—	Series Unknown
Kaiteng Venture Capital	—	Series Unknown